Thursday, August 11, 2022
News
NEWS HOME
»
PRN INDIA
Menarini Group and Radius Health Submit New Drug Application to the U.S. FDA for Elacestrant
  SocialTwist Tell-a-Friend  
   

  • Intended for potential treatment of ER+/HER2- advanced or metastatic breast cancer patients
  • Priority Review requested; if accepted, anticipate an 8-month FDA review
  • Positive EMERALD study data previously announced on October 20, 2021
  • First, and currently only, investigational oral SERD with positive topline results
  • Additional data presented at SABCS (December 2021) and ASCO (June 2022)
  • Plan to file marketing authorization application for elacestrant in the EU in 2H 2022

FLORENCE, Italy and BOSTON, June 22, 2022 /PRNewswire/ -- The Menarini Group ("Menarini") and Radius Health, Inc. ("Radius") (NASDAQ: RDUS) (collectively, the "Companies") announced that Menarini, with support from Radius, has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for elacestrant in patients with ER+/HER2- advanced or metastatic breast cancer.

Menarini Group Logo

As part of the submission, the Companies have requested Priority Review with the FDA. If Priority Review is granted, the Companies anticipate that the FDA would conduct an 8-month review, incorporating a 6-month priority designation review.

The NDA submission is based on positive phase 3 data from the EMERALD study that was previously announced on October 20, 2021. EMERALD met both of its primary endpoints, which were progression-free survival (PFS) in the overall population and PFS in the estrogen receptor 1 (ESR1) mutation subgroup as compared to standard of care (SoC) with the options of fulvestrant or an aromatase inhibitor.

Elacestrant is the first and currently only investigational oral SERD to show positive topline results in a pivotal trial for the treatment of ER+/HER2- advanced or metastatic breast cancer in postmenopausal women, and men. Notably, these results showed elacestrant is also active in patients whose tumors harbor an ESR1 mutation, one of the key resistance mechanisms that develops in later treatment lines of metastatic breast cancer.

Following the completion of EMERALD, data from the study was presented at the San Antonio Breast Cancer Symposium (SABCS) on December 8, 2021, published in the Journal of Clinical Oncology (JCO) on May 18, 2022, and further subset analyses were presented at the 2022 American Society of Clinical Oncology (ASCO) annual Meeting on June 6, 2022.

Elcin Barker Ergun, the Chief Executive Officer of Menarini, commented, "We are excited about the potential for elacestrant to be approved for treatment of patients with advanced or metastatic ER+/HER2- breast cancer, which constitutes about 70% of breast cancer and remains an area of significant unmet medical need." Barker Ergun continued, "Elacestrant has shown statistically significant efficacy over current standard of care medications both for overall population and in patients whose tumors harbor an ESR1 mutation, one of the most difficult to treat mechanisms of acquired resistance that develops in the later stages of metastatic/advanced breast cancer."

Chhaya Shah, SVP of Clinical and Regulatory at Radius, commented, "We enrolled and completed the EMERALD trial in a high-quality manner, delivered positive topline results, and prepared the submission of the NDA to the FDA. The submission is a significant milestone for both companies, and we appreciate the strong, collaborative effort of many hard-working employees at Radius and Menarini, investigators, patients, and their families. Together we look forward to advancing elacestrant and providing the opportunity to benefit patients."

Nassir Habboubi, Global Head of Pharma R&D of Menarini Group, added, "The Menarini and Radius teams have done an excellent job working together since our partnership began in July of 2020." Habboubi continued, "We plan to test elacestrant in earlier treatment lines, combination trials, and metastatic breast cancer that has metastasized to the brain. These details are to be communicated by us throughout 2H 2022 and 1H 2023."

With the submission of the NDA, based on the original agreement of the Companies, Menarini takes over activities and will be responsible for registration and commercialization. Menarini plans to use its fully owned subsidiary in the U.S., Stemline Therapeutics, to commercialize elacestrant if approved by the FDA.

About Elacestrant (RAD1901) and EMERALD Phase 3 Study
Elacestrant is an investigational selective estrogen receptor degrader (SERD), out-licensed to Menarini Group, which is being evaluated for potential use as a once daily oral treatment in patients with ER+/ HER2- advanced breast cancer. In 2018, elacestrant received fast track designation from the FDA. Preclinical studies completed prior to EMERALD indicate that the compound has the potential for use as a single agent or in combination with other therapies for the treatment of breast cancer. The EMERALD Phase 3 trial is a randomized, open label, active-controlled study evaluating elacestrant as second- or third-line monotherapy in ER+/HER2- advanced/metastatic breast cancer patients. The study enrolled 477 patients who have received prior treatment with one or two lines of endocrine therapy, including a CDK 4/6 inhibitor. Patients in the study were randomized to receive either elacestrant or the investigator's choice of an approved hormonal agent. The primary endpoint of the study was progression-free survival (PFS) in the overall patient population and in patients with estrogen receptor 1 gene (ESR1) mutations. Secondary endpoints included evaluation of overall survival (OS), objective response rate (ORR), and duration of response (DOR).

About Menarini
The Menarini Group is a leading international pharmaceutical and diagnostics company, with a turnover of over $4 billion and over 17,000 employees. Menarini is focused on therapeutic areas with high unmet needs with products for cardiology, oncology, pneumology, gastroenterology, infectious diseases, diabetology, inflammation, and analgesia. With 18 production sites and 9 Research and Development centers, Menarini's products are available in 140 countries worldwide. For further information, please visit www.menarini.com.

About Radius
Radius is a global biopharmaceutical company focused on addressing unmet medical needs in the areas of bone health, orphan diseases, and oncology. Radius' lead product, TYMLOS ® (abaloparatide) injection, was approved by the U.S. Food and Drug Administration for the treatment of postmenopausal women with osteoporosis at high risk for fracture. The Radius clinical pipeline includes investigational abaloparatide injection for potential use in the treatment of men with osteoporosis; the investigational drug, elacestrant (RAD1901), for potential use in the treatment of hormone-receptor positive breast cancer out-licensed to Menarini Group; and the investigational drug RAD011, a synthetic cannabidiol oral solution with potential utilization in multiple neuro-endocrine, neurodevelopmental, or neuropsychiatric disease areas, initially targeting Prader-Willi syndrome, Angelman syndrome, and infantile spasms.

Forward-Looking Statements of Radius
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. All statements contained in this press release that do not relate to matters of historical fact should be considered forward-looking statements, including without limitation statements regarding the potential for elacestrant for the treatment of patients with advanced ER+/HER2- breast cancer, including the potential to be a new standard of care, the length of priority review, if granted, of the elacestrant NDA by the FDA, the expected regulatory submission in the European Union; and ongoing clinical development activities with respect to elacestrant.

These forward-looking statements are based on Radius management's current expectations. These statements are neither promises nor guarantees, but involve known and unknown risks, uncertainties and other important factors that may cause our actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements, including, but not limited to, the following: the adverse impact the ongoing COVID-19 pandemic, including the delay of reviews and approvals by the FDA and other regulatory authorities, delays in the supply of drug product, risks related to Radius' collaboration with Menarini, including its ability to scale its sales and marketing operations if elacestrant is approved for marketing; Menarini's ability to obtain favorable pricing and reimbursement for elacestrant, if approved; the risk that the potential market for elacestrant is not as anticipated; the risk of adverse side effects related to elacestrant are identified; risks related to manufacturing, supply and distribution of elacestrant; and the risk of litigation or other challenges regarding Radius' intellectual property rights. These and other important risks and uncertainties discussed in Radius' filings with the Securities and Exchange Commission (SEC), including under the caption "Risk Factors" in Radius' Annual Report on Form 10-K for the year ending December 31, 2021 and subsequent filings with the SEC, could cause actual results to differ materially from those indicated by the forward-looking statements made in this press release. Any such forward-looking statements represent Radius' management's estimates as of the date of this press release. While Radius may elect to update such forward-looking statements at some point in the future, Radius disclaims any obligation to do so, even if subsequent events cause our views to change. These forward-looking statements should not be relied upon as representing Radius' views as of any date subsequent to the date of this press release.

Logo - https://mma.prnewswire.com/media/652491/MENARINI_Group_Logo.jpg

More News by PR Newswire India

DENTSU RECOGNIZED AS A STRONG PERFORMER IN GLOBAL MARKETING SERVICES REPORT BY INDEPENDENT RESEARCH FIRM

Deltek Announces Speakers and Sponsors for Deltek ProjectCon 2022

Yellow.ai announces the launch of its proprietary DynamicNLP™, a first in the enterprise Conversational AI space

TUMI announced as Official Luggage Partner of Tottenham Hotspur Women's Pre-Season Tour

WITH 40+ NEW INSTALLATIONS, QATAR PRESENTS MORE THAN 100 MAJOR WORKS OF PUBLIC ART AHEAD OF THE FIFA WORLD CUP QATAR 2022™

NuraLogix researchers announce AI models that can predict Metabolic Risks

A TROPICAL ESCAPE WITH ULTIMATE EXPERIENCES AT THE RITZ-CARLTON, BALI

CU UCRD's bio-insecticide to revolutionise India's fruit production

No-Code DevOps platform Humalect raises $ 750k in seed round led by StartupXseed Ventures

ONE Advertising - the creative force behind Divya Bhaskar's Sachi Vaat Bedhadak campaign

Sennheiser announced exciting deals on its best-selling products during the Amazon Great Freedom Festival Sale 2022

YES BANK and IBSFINtech tie up to provide enhanced digital services for corporate clients

Multi-Blockchain Wallet App Nufinetes Releases New Feature to View NFTs on Ethereum and VeChain

impress.ai and Aon to help employers improve hiring accuracy, streamlining the end-to-end recruitment process

Shivalik Bimetal posts solid Q1FY23 top and bottom lines YoY, on the back of resurging global demand

Edvoy CEO, Sadiq Basha, named Visionary Entrepreneur of the Year 2022 by WPI

Indo Amines Limited declares tremendous growth, Operational Revenue up by 46%

Over 550,000 people set to attend the International Saudi Falcons and Hunting Exhibition in Malham, Riyadh

HPL Electric and Power Ltd reports solid Q1FY23 Results

Spinny's Take on the Swiftly Changing Automobile Industry

World's Largest Fintech Conference is Back

15th Singapore International Energy Week (SIEW) Registration Now Open

Indian WWW Treatment Market to Experience a Boom as the Country witnesses increase in Private Investments

Khadim India records 190% growth in Retail Sales in Q1 FY 23

MedAlliance SELUTION SLR Receives Second FDA IDE Approval

Adda52 announces 'Freedom Fest' - an online Poker tournament to celebrate 75 years of Independence

Online Proctoring Solution Provider Shinkan Launches Shinkan Edge To Revolutionise Corporate Recruitment

The 49th CIFF Guangzhou Presents the Entire Furniture Supply Chain to 50 Million Visitors Online and Offline

Xinhua Silk Road: N.China's Lingqiu County takes organic agriculture as effective way to promote rural development

EARTHDAY.ORG'S THE CANOPY PROJECT ANNOUNCES MANGROVE PLANTING PROJECT IN BANGLADESH WITH CRYSTAL INTERNATIONAL GROUP LIMITED

Here and Now, There and Then: Prince Mohammad Bin Fahd University Drives Innovation and Invention, Locally and Globally

Global supply chain reconfiguration to persist through 2030

Hakuhodo and DAC launch H+, a strategic group to "Empower Your Digital Future" with one of APAC's most distinctively audience-centric data marketing approaches

ONESIGHT ESSILORLUXOTTICA FOUNDATION ANNOUNCES PUBLICATION OF NEW ARTICLE

Recorded Future Launches National Cyber Defense Intelligence Kit

Launched to immediate global acclaim via Livestream: Absen's pioneering KLCOB Micro LED product series

SEMI Applauds President Biden's Signing of CHIPS and Science Act of 2022

Anthony Di Iorio Opens Whitelist for New Global Project to Empower a User-Controlled Internet; Project to Be Unveiled November 3

New measures agreed to strengthen the partnership between Mongolia and China

Focused Photonics Inc. Selects Wolters Kluwer CCH® Tagetik Expert Solution for its Disclosure Management Needs

Snapmaker Announces Artisan 3-in-1 3D Printer is Available for Pre-order Today

Frost & Sullivan Institute Recognizes Samsung Biologics with the 2022 Global Enlightened Growth Leadership Award for its Commitment to Sustainable Growth

DevOps Institute Releases First Ever 'Global SRE Pulse 2022' Report

WorkForce Software Honored Alongside IBM and Google in Comparably's Annual Ranking of Top Companies for Having the Best Leadership Team

Aon appoints James Platt as Chief Digital Officer and Mindy Simon joins the firm as Chief Operating Officer

Merck Becomes One of the First CDMOs to Provide Full Viral Vector Offering with Launch of VirusExpress® 293 Adeno-Associated Virus Production Platform

Satellite Software Innovator Antaris Announces Close of $4.2 Million Seed Funding Round to Accelerate Development of Software Solutions for Space

GOLDIAM reports its Q1FY23 results, share of Lab grown diamond & jewellery strengthens further

Novaliq submits New Drug Application seeking approval for first-of-a-kind Dry Eye Disease Treatment CyclASol®

Nobu Hospitality Expands its Footprint in Asia Pacific

Gunzilla Games Raises $46M to Redefine the Battle Royale Genre By Letting Players Trade Their In-Game Items in "Off The Grid"

Deepak Nitrite Demonstrates Strong Topline Performance with 35% Y-o-Y Growth

A leading ERP company, Focus Softnet eyes revenues of 160 crores, projects a growth of about 20% Y-O-Y

Quest Global Becomes Arm Approved Design Partner

GCLSI Receives French Carbon Footprint Certification for Its 182 and 210 Series of Photovoltaic Modules

Triumph International India launches their first exclusive retail store in Pune

Indian Ice-Cream Manufacturers' Association (IICMA) met with Finance Minister Nirmala Sitharaman to discuss GST rates on supply of ice cream by ice cream parlours in India

Dyninno opens new office in Cyber City; Plans more offices in Gurugram and Mumbai

Woxsen University bestows Chair Professorships in honour of International Experts

People Matters TechHR 2022 Brings Fresh Eyes to the World of HR

PACORR Launches Melt Flow Index Tester - Fully Automatic Version

RateGain Launches Airline Travelers' Forecast to Help Commercial Teams Drive Higher ROI

Thai Digital Content Gaining Increasing Recognition Around the World

Crave InfoTech launches White Paper on Top Supply Chain Challenges

GRL accelerates the authorization of biometrics devices for Government of India projects

Everest Group Names Automation Anywhere a Leader in the inaugural Task Mining PEAK Matrix® Assessment 2022

China Wuling's First Global Electric Vehicle Air ev Rollouted, First Step In Indonesia

FRONTIER BIOTECHNOLOGIES ANNOUNCES POSITIVE PHASE 1 RESULTS OF ITS FIRST CORONAVIRUS MAIN PROTEASE (MPRO) SMALL MOLECULE INHIBITOR, LAYING FOUNDATION FOR THE TREATMENT OF ACUTE AND LONG COVID

GIGABYTE Releases 600 series BIOS updates ready for Intel's upcoming new-gen processors

Soroco Named a Leader in Everest Group's PEAK Matrix® for Task Mining Technology Provider 2022

Starburst Celebrates 10th Anniversary of Trino

Point-of-Care Ultrasound Certification Academy to Host World Conference

The "Picturesque and Dynamic Zhejiang" Global Short Video Competition Launches

BlackBerry Commended by Frost & Sullivan for Optimizing Edge-to-cloud Performance, Security, Privacy, and Scalability with its IVY Platform for Automakers

Amwell Applauded by Frost & Sullivan for its Comprehensive Digital Care Delivery Enablement Platform, Converge™

Prominent Stanford University scientist and cellular reprogramming innovator will oversee all research for Turn Bio

Axis Bank in partnership with CRMNEXT wins the Best CRM Implementation Award by Asian Banker

Godrej Properties Ltd. unveils insights from Home Livability Factors research

Gear Up with All New Helix Metalfit 3.0 Smartwatch Launched by Timex Group India

Roundtable with Leading Doctors and Youth Aims for a Tobacco-Free Future for India

Catalytic Investment to Improve Community Health Care for Millions Across Africa

DIFC Launches First Global Family Business and Private Wealth Centre

2022 ITOE - Home Lifestyle Expo Opens, Provides Strong Impetus for Development of Digital Trade

FRIMLINE LAUNCHES INDIA'S 1st ORAL CARE RANGE FOR PREGNANT WOMEN

Aptus Value Housing Finance India Limited announces Q1 FY23 Results

Tata Communications enhances InstaCC™ Platform with digital features

/C O R R E C T I O N -- Lentra/

Leading Solar Energy Solution Provider Haitai Solar Launches IPO on Beijing Stock Exchange

Kiko Live to be launched on ONDC in September

Clarivate Selected by Singapore's National Library Board to Play a Part in Building Libraries of the Future

TCL Reaffirms its Leadership in Mini LED TVs in 2022

NID Foundation unveils Heartfelt-The Legacy of Faith; A book showcasing PM Modi's relationship with the Sikh community at Melbourne

AirCarbon Exchange Offsets Emissions Through to December 2023

Celebrate independence from the worries of interest rates with Tata Housing Development Company's 'Its Interesting' campaign with 3.50% interest rate for 12 months in the 75th year of Independence

Xinhua Silk Road: E. China's Wuxi city steps up biomedical industry development

M/V Riva Wind and M/V Arizona Both Sail from Ukraine with 105,000 Tons of Grain

Atlanta Site Strengthens Sims Lifecycle Services' Operational Footprint

PRA Group Leader LaTisha Tarrant Named Chief Human Resources Officer

Media Advisory - BMO Financial Group to Announce its Third Quarter 2022 Results

Vieworks Wins FDA Approval for Its Newest VIVIX-S F series

GACL Financial results for the first quarter ended 30th June 2022

Strong Technical Advantages of TANK Platform, GWM TANK300 Will Bring a New Intelligent Off-road Experience

Bitget Launches $200 Million Protection Fund To Safeguard Users' Asset Security

Chandigarh University joins hands with Punjab Remote Sensing Centre for resources management and disaster mitigation

Saudi Arabia to Bid for the 2026 AFC Women's Asian Cup

FIRMENICH DELIVERS RECORD RESULTS DESPITE CHALLENGING MACRO-ECONOMIC ENVIRONMENT

A Center of Hope and New Life

CHAIRMAN OF ATLAS CORP., FAIRFAX FINANCIAL HOLDINGS LIMITED AND THE WASHINGTON FAMILY PARTNER WITH OCEAN NETWORK EXPRESS PTE. LTD. TO JOINTLY PROPOSE ACQUIRING ALL COMMON SHARES OF ATLAS CORP. NOT CONTROLLED BY ITS MAJORITY SHAREHOLDERS FOR $14.45 PER SHARE IN CASH

Hon'ble Prime Minister Modi inaugurates multispecialty charitable Shrimad Rajchandra Hospital; a revolution in rural healthcare

PARAMOUNT PICTURES' "TOP GUN: MAVERICK" FLIES PAST $50 MILLION IN SCREENX AND 4DX

Empowering Young Women and Refugees Worldwide through STEM & Sustainability

ViewSonic's Visual Solutions Ignite Love and Hope in 2022 World Women's Art Festival

Besrey Celebrates Seventh Anniversary with Giveaways and Gifts for Parents

ADVENTURERS ROSS EDGLEY AND KATIE TUNN OPEN DOORS AT NEW TALISKER VISITOR EXPERIENCE

Frost & Sullivan Institute lauds Global Companies with Prestigious Enlightened Growth Leadership Awards

Oracle Names WorkForce Software the Cloud HCM ISV Partner of the Year as Winner of the 2021 Oracle Cloud HCM HR Heroes Visionary Award

In a first of its kind, Rural Banking Outlets in India to get a distinct identity through 'RedBlue Revolution'

Titan.ium Platform, LLC Announces 5G SA Evolution of NetCore to Expand Its Private Networks Solutions

Dentsu Group Acquires a Majority Stake in Extentia to Strengthen Customer Transformation and Technology Capabilities

Agility Completes ÂŁ763 Million Acquisition of Menzies Aviation

Elearnmarkets goes global with their 2nd edition of the Face2Face Trading Conclave in Bangkok

Global Tree presents Study Fair 2022

Innoviti joins ONDC platform to help small sellers accelerate sales through co-promotion opportunities with banks and brands

VNPT Group partners with Comviva to deliver advanced digital customer experience

SVKM'S NMIMS Shirpur campus bags NBA accreditation for School of Pharmacy & Technology Management

Crest, an Inventory Planning Tool Gets Funding from Its first 2 Customers, Sirona Hygiene and Samosa Party

Panchshil Realty To Sponsor Accomplished Mountaineer Baljeet Kaur's Next Adventure

The Adecco Group: HALF YEAR REPORT 2022

The Adecco Group: Q2 22 Results - Market share momentum, solid growth and margin

Cielo continues global expansion, opens new office in India

VCTI Achieves Dramatic Growth Fueled by U.S.'s Plans and Funding for Broadband Expansion

Sun Life Appoints Chris Wei to EVP and Chief Client and Innovation Officer

ROSHN signs agreement to sponsor and rename Jeddah Waterfront

GameChange Solar Announces 6 GW Midwest Tracker Factory, Increases USA Capacity to 14 GW

Franklin Templeton, Inc. Renews with Empire State Realty Trust for 79k Square Feet at 100 First Stamford Place

Music industry veteran Lefroy Verghese joins Audio Network

Women's World Banking Announces 2023 Fintech Innovation Challenge to Elevate Fintechs with New Solutions to Close the Gender Gap in Financial Services

KPM Analytics Introduces New Discrete Analyzer to Complete Its SmartChem® Product Line

HAVAS HEALTH & YOU PARTNERS WITH REPUBLICA HAVAS TO CREATE REPUBLICA HAVAS HEALTH

Collaboration of ePayLater, the SME Credit Platform with JioMart Partner

Firmenich Appoints Maurizio Clementi ad interim President of its Taste & Beyond Division

Enfinity Global closes $242 million of long term financing for three operational solar power plants in Japan

HIGHLIGHTS FROM THE ALZHEIMER'S ASSOCIATION INTERNATIONAL CONFERENCE 2022

HISTORY OF HYPERTENSIVE DISORDERS DURING PREGNANCY LINKED TO INCREASED RISK OF DEMENTIA

HarperCollins Publishers India is proud to announce the forthcoming publication of Chitra Banerjee Divakaruni's new novel INDEPENDENCE

Waterborne Trade in Rio South Texas

A Bond Tightly Woven Together With Sneh - An Exquisite Rakhi Range From Ferns N Petals (FNP)

FMCG and Consulting companies top recruiters at SPJIMR Autumn Internship 2022

Jury unveiled for UXplorer'22; features design industry stalwarts from India and abroad

Hisense Shines in UEFA Women's EURO 2022™, Achieved Champion Position in Global Market

The Israeli Ministry of Defense Selects Mona's Enterprise Monitoring Solution to Gain Complete Visibility into Their AI / ML Systems

Over 22% of small businesses that availed loans in FY 2022 were run by women: NeoGrowth Social Impact Report

FORTUNE RELEASES ANNUAL FORTUNE GLOBAL 500 LIST

Technology Solutions to Boost Employee Experience and Improve Patient Outcomes

Cendyn announces acquisition of digitalhotelier

Credgenics launches Digital Collections Technology Platform in Indonesia

MOMENTUM NAMED A BEST COMPANY TO WORK FOR WITH "OUTSTANDING" LEVELS OF WORKPLACE ENGAGEMENT

Zimyo at-service with its 'Start-up Program'

Sanjay Ghodawat conferred with the Maharashtra Leadership Award 2022

Jio Platforms partners with Subex HyperSense AI to augment its 5G product line

Globalization Partners Again Named an Industry Leader in NelsonHall's 2022 Global Employer of Record Research

Detect Technologies announces global agreement with Vedanta

CLA Nearly Triples Office Space with ESRT at One Grand Central Place

Sparrow Introduces Newly Updated Sparrow Cloud and Sparrow SCA at Black Hat USA 2022

CELEBRATING CULTURAL REVIVAL AND THE TRADITION OF PASSING ON GENERATIONAL KNOWLEDGE THROUGH A NEW ROYAL CANADIAN MINT COIN HONOURING THE RED RIVER MÉTIS

LOWER SOCIOECONOMIC STATUS IN CHILDHOOD, PERSISTENT LOW WAGES LINKED TO RISK FOR DEMENTIA AND FASTER MEMORY DECLINE

Expel Applauded by Frost & Sullivan for Enabling Managed and Automated Threat Detection and Response

Context Therapeutics and The Menarini Group Announce Clinical Trial Collaboration and Supply Agreement to Evaluate ONA-XR and Elacestrant Combination

Bigtincan Unveils Analytics Experience and Delivers Enhancements to Award-Winning Sales Enablement Platform

Zift Solutions Marks Six Years of SOC 2 Compliance

Adorable has a new meaning with Little Surprise Box the pioneers of Kids Monsoon Fashion in India

Firmenich Announces Grand Opening of West Coast Pilot Plant for Food & Beverage Customers

Leica Camera engages in the Laser TV equipment segment and agrees on technological cooperation with Hisense

Metabolon Awarded ISO 9001:2015 Recertification

At Chandigarh University, multiple scholarships worth Crores of rupees help talented and meritorious students overcome the barrier of weaker economic situation

Altair Announces Winners of 10th Annual Enlighten Award

iHerb Achieves Customer Service Milestones

10,000 RMB! "My Guangdong Story" short video solicitation calls for global entries

STL launches comprehensive optical suite for India's 5G readiness

LambdaTest's intelligent test orchestration platform HyperExecute is now available on the Microsoft Azure Marketplace

Northwest Analytics Applauded by Frost & Sullivan for Preventing Institutional Knowledge Loss and Bridging Skills Gaps with NWA Analytics Knowledge Suite™

New Research Reveals Risk Factors to Business Success in a Post-Pandemic World

Comviva receives Mastercard Cloud Based Payments Certification

EZVIZ LAUNCHES TY1 With 4MP, A SMART Wi-Fi PAN and TILT CAMERA

Novel and fast typing method developed to control monkeypox by Molecular Biology Systems (MBS) in collaboration with the Amsterdam UMC and Danish Rigshospitalet

Intersec Reports Most Successful Fiscal Year In Company History

Protean forays into cyber security business, launches Protean InfoSec Services Limited

Prudent Corporate Advisory Services Limited Profits grew by 25% YoY & Flows from SIPs Reach Highest Ever in Q1FY23

Pharming Announces New ICD-10-CM Code for APDS, a Rare Primary Immunodeficiency

SEERIST ESTABLISHES THE FIRST AUGMENTED ANALYTICS TECHNOLOGY FOR SECURITY AND THREAT INTELLIGENCE PROFESSIONALS

Quinnox named a Strong Performer in Modern Application Development Services by Independent Analyst Firm

 
 
TRENDING TOPICS
 
 
CITY NEWS
MORE CITIES
 
 
INDIA WORLD ASIA
Partha Chatterjee's offence doesn't make...
YSRCP MP's video on social media not ori...
Maha: Independents, smaller parties fume...
Kashmir school named after Sarwanand Kou...
Bouncers beat up 6 including 4 women at ...
CM change rumours rattle BJP in K'taka; ...
More...    
 
 Top Stories
Hyd doctor gets 10 years jail for s... 
Pakistani boxers go missing from Bi... 
Yogi model in K'taka: Cops attach p... 
Arjun Kanungo, Carla Dennis ties kn... 
Walayar minor sisters' rape-death c... 
Nepal Foreign Minister Khadka holds... 
Army chief General Manoj Pande feli... 
Will Trump show up at New York AG's...